ARTHRITIS DRUGS

Journal Watch, Litigation Watch-Arthritis Drugs, May 2005


May 9, 2005



Incidence of Thrombotic Cardiovascular Events in Patients Taking Celecoxib Compared with Those Taking Rofecoxib: Interim Results from the New Zealand Intensive Medicines Monitoring Programme Journal: Drug Safety. 2005;28(5):435-42 Authors: M. Harrison-Woolrych, P. Herbison, R. McLean, J. Ashton, J. Slattery Summary: The study aimed to compare the incidence of thrombotic cardiovascular in patients taking Celebrex and those taking Vioxx. The researchers examined information from a cohort of New Zealand patients - 26,403 of whom had taken Vioxx and 32,446 who were prescribed Celebrex. A total …

Subscribe Now Purchase Article for $40.00



UPCOMING CONFERENCES




HarrisMartin's Data Breach Litigation Conference

March 26, 2025 - Charlotte, NC
Omni Charlotte Hotel

MORE DETAILS



HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference

April 08, 2025 - Long Beach, CA
The Westin Long Beach

MORE DETAILS